Medicamen Organics Limited launches IPO, 31,00,000 shares worth INR 10.54 cr to fund product registration, plant updates, production boosts, working capital, and corporate needs.
Open Date : June 21, 2024 Close Date : June 25, 2024 Allotment Date: June 26, 2024 Listing Date: June 28, 2024
IPO Price: INR 32-34 per share Lot Size: 4000 Shares Total Issue Size: INR 10.54 crores
Medicamen Organics analysis shows mixed performance: 1. Revenue increased,Equity & profitability improved. 2. EPS & RoNW rose,Total assets grew. 3. Inventory turnover decreased, indicating potential inefficiencies.
Medicamen Organics Ltd: 1. Strong profitability and RoNW compared to Brooks Labs & Zenotech Labs. 2. Lower revenue but higher EPS and solid financial ratios, showing stability.
Medicament Organics Ltd main objective: 1. Fund international product registration expenses. 2. Update & expand plant capacity. 3. Support working capital requirements.
Medicament Organics Ltd risks: 1. Litigation involvement. 2. Pending licenses and permits. 3. Reliance on third-party suppliers. 4. Potential impacts on operations, finances & reputation.